These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6166691)

  • 1. Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.
    Scullard GH; Pollard RB; Smith JL; Sacks SL; Gregory PB; Robinson WS; Merigan TC
    J Infect Dis; 1981 Jun; 143(6):772-83. PubMed ID: 6166691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
    Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside.
    Scullard GH; Andres LL; Greenberg HB; Smith JL; Sawhney VK; Neal EA; Mahal AS; Popper H; Merigan TC; Robinson WS; Gregory PB
    Hepatology; 1981; 1(3):228-32. PubMed ID: 6169615
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiviral treatment of chronic hepatitis B virus infection: infectious virus cannot be detected in patient serum after permanent responses to treatment.
    Scullard GH; Greenberg HB; Smith JL; Gregory PB; Merigan TC; Robinson WS
    Hepatology; 1982; 2(1):39-49. PubMed ID: 6172352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection.
    Smith CI; Kitchen LW; Scullard GH; Robinson WS; Gregory PB; Merigan TC
    JAMA; 1982 Apr; 247(16):2261-5. PubMed ID: 6175774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between HBV-specific DNA polymerase and HBe antigen/antibody system in chronic HBV infection: factors determining selection of patients and outcome of antiviral therapy.
    Craxi A; Weller IV; Bassendine MF; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
    Gut; 1983 Feb; 24(2):143-7. PubMed ID: 6852624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological response of HBsAg-positive chronic active hepatitis to adenine arabinoside: lack of correlation with DNA polymerase response.
    Liaw YF; Lin DY; Chen TJ; Chu CM; Sheen IS
    Infection; 1984; 12(4):248-50. PubMed ID: 6490167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
    Buti M; Jardi R; Rodriguez-Frias F; Allende H; Cotrina M; Esteban R; Guardia J
    J Med Virol; 1996 Aug; 49(4):325-8. PubMed ID: 8877766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. A long-term follow-up study.
    Omata M; Uchiumi K
    J Hepatol; 1986; 3 Suppl 2():S65-9. PubMed ID: 2439578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of human leucocyte interferon on hepatitis B virus replication and immune responses in patients with chronic hepatitis B infection.
    Scullard GH; Alberti A; Wansbrough-Jones MH; Howard CR; Eddleston AL; Zuckerman AJ; Cantell K; Williams R
    J Clin Lab Immunol; 1979 Feb; 1(4):277-82. PubMed ID: 501726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.
    Lok AS; Novick DM; Karayiannis P; Dunk AA; Sherlock S; Thomas HC
    Hepatology; 1985; 5(6):1132-8. PubMed ID: 2415436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of ARA-AMP on serum DNA polymerase activity and serum HBV-DNA in chronic hepatitis B virus infection. A possible reason for lack of efficacy.
    Alexander GJ; Fagan EA; Rolando N; Guarner P; Callender ME; Eddleston AL; Williams R
    J Hepatol; 1986; 3 Suppl 2():S81-6. PubMed ID: 2439580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination.
    Sacks SL; Scullard GH; Pollard RB; Gregory PB; Robinson WS; Merigan TC
    Antimicrob Agents Chemother; 1982 Jan; 21(1):93-100. PubMed ID: 6177285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responses.
    Hafkin B; Pollard RB; Tiku ML; Robinson WS; Merigan TC
    Antimicrob Agents Chemother; 1979 Dec; 16(6):781-7. PubMed ID: 533259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study.
    Yokosuka O; Omata M; Imazeki F; Hirota K; Mori J; Uchiumi K; Ito Y; Okuda K
    Gastroenterology; 1985 Aug; 89(2):246-51. PubMed ID: 4007415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the antiviral effects of adenine arabinoside on chronic HBV infection.
    Watanabe S; Saito S; Yoshikawa A; Shibayama T; Kamimura T; Suzuki S; Ischida F
    Hepatogastroenterology; 1982 Jun; 29(3):102-5. PubMed ID: 7106692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of the chronic hepatitis B virus carrier state.
    Lever AM
    J Infect; 1988 May; 16(3):221-9. PubMed ID: 2456355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenine arabinoside 5'-monophosphate treatment of chronic type B hepatitis.
    Hoofnagle JH; Minuk GY; Dusheiko GM; Schafer DF; Johnson R; Straus S; Jones EA; Gerin JL; Ishak K
    Hepatology; 1982; 2(6):784-8. PubMed ID: 6183183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.
    Suzuki Y; Kobayashi M; Ikeda K; Suzuki F; Arfase Y; Akuta N; Hosaka T; Saitoh S; Kobayashi M; Someya T; Matsuda M; Sato J; Watabiki S; Miyakawa Y; Kumada H
    J Med Virol; 2005 May; 76(1):33-9. PubMed ID: 15779048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.